2016
Differences in Active and Passive Smoking Exposures and Lung Cancer Incidence Between Veterans and Non-Veterans in the Women’s Health Initiative
Bastian LA, Gray KE, DeRycke E, Mirza S, Gierisch JM, Haskell SG, Magruder KM, Wakelee HA, Wang A, Ho GY, LaCroix AZ. Differences in Active and Passive Smoking Exposures and Lung Cancer Incidence Between Veterans and Non-Veterans in the Women’s Health Initiative. The Gerontologist 2016, 56: s102-s111. PMID: 26768384, PMCID: PMC5881614, DOI: 10.1093/geront/gnv664.Peer-Reviewed Original ResearchConceptsPassive smoking exposureWomen's Health InitiativeSmoking exposureLung cancer incidenceLung cancerWomen veteransHealth initiativesCancer incidenceHigh riskCox proportional hazards modelLung cancer incidence ratesOlder women veteransPassive tobacco exposureCancer incidence ratesProportional hazards modelHigh ratePostmenopausal womenPack yearsPassive smokingTobacco exposureProspective dataIncidence rateNon-VeteransTobacco useHazards model
2014
Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans
Shofer S, Beyea M, Li S, Bastian LA, Wahidi MM, Kelley M, Lipkus IM. Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans. BMJ Open Respiratory Research 2014, 1: e000032. PMID: 25478181, PMCID: PMC4212704, DOI: 10.1136/bmjresp-2014-000032.Peer-Reviewed Original ResearchLung cancer riskLung cancerSmoking cessationCancer riskMethylated p16Time of enrollmentAcceptance of testingCent of participantsAirway obstructionActive smokersCurrent smokersCessation assistanceTobacco exposureCessation ratesUS veteransEpigenetic markersSmokersMethylation of p16P16 methylationCancerP16SmokingEducational materialsRiskEducational presentations